Search results
Jun 26, 2023 · Eli Lilly’s Mounjaro, cleared for type 2 diabetes and awaiting FDA approval for weight loss, targets both GLP-1 and a hormone called GIP, and has produced weight loss of 21 to 23%.
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
Feb 15, 2024 · This article will discuss eight current Food and Drug Administration (FDA)–approved weight loss drugs on the market.
Nov 8, 2023 · The Food and Drug Administration on Wednesday approved an obesity drug from the company Eli Lilly that will be a direct competitor to the wildly popular Wegovy. The drug is called tirzepatide...
Nov 8, 2023 · The FDA has approved Zepbound, an injectable weight loss drug from Eli Lilly that helped people lose up to 52 lbs in 16 months during clinical trials.
Nov 9, 2023 · The FDA’s approval of tirzepatide, following the approval of semaglutide in 2021, gives doctors and patients two of the most potent drugs yet to treat weight loss.
Nov 8, 2023 · The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of a medicine already widely...
Nov 8, 2023 · The decision by the Food and Drug Administration on Wednesday to approve the weight loss drug tirzepatide adds a potent new tool to the fast-growing arsenal of obesity drugs.
Jun 10, 2021 · The FDA on Friday approved a new weight-loss drug, Wegovy, for people who are either obese or overweight and have at least one weight-related medical problem.
Jun 4, 2021 · The Food and Drug Administration approved Wegovy, a higher-dose version of Novo Nordisk's diabetes drug semaglutide, for long-term weight management.
